Related Experiment Video
Updated: Jun 22, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination
Christos Thomadakis1, Dimitrios Basoulis2, Olga Tsachouridou3
1Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
Insights
This study tracked Hepatitis C care for people with HIV-HCV co-infection in Greece. Significant gaps and disparities in care persist, especially for migrants and people who inject drugs, impacting treatment outcomes.
Area of Science:
- Infectious Diseases
- Public Health
- Hepatology
Background:
- People with HIV-HCV co-infection are a key group for Hepatitis C virus (HCV) micro-elimination efforts.
- Understanding the HCV cascade of care (CoC) is crucial for improving outcomes in this vulnerable population.
- Greece's HIV-HCV co-infected population presents unique challenges and opportunities for HCV elimination.
Purpose of the Study:
- To analyze the HCV cascade of care (CoC) among HIV-HCV co-infected individuals in Greece.
- To identify factors influencing progression through each stage of the HCV care continuum.
- To assess disparities in HCV care and treatment outcomes across different subgroups.
Main Methods:
- Analysis of data from 1213 participants in the Athens Multicenter AIDS Cohort Study.
- Construction of a seven-stage HCV CoC, from diagnosis to sustained virologic response (SVR).
- Application of logistic and Cox regression models to identify factors associated with CoC progression.
Main Results:
- Mortality before direct-acting antiviral (DAA) availability was 9.2%, with higher rates among people who inject drugs (PWID).
- Retention in care and HCV-RNA testing rates were lower for migrants and PWID.
- While 71% initiated DAAs, very low CD4 counts (<100 cells/μL) were linked to lower initiation odds; SVR rates were high (85.7%) and consistent across groups.
Conclusions:
- Significant gaps and between-group differences persist in the HCV CoC for HIV-HCV co-infected individuals in Greece as of 2023.
- Targeted interventions are needed to improve care access and outcomes for marginalized subgroups, including migrants and PWID.
- Despite challenges, high SVR rates post-DAA treatment indicate the potential for HCV elimination with optimized care pathways.
Abstract:
People living with HIV-HCV co-infection comprise a target group for HCV-micro-elimination. We conducted an HCV cascade of care (CoC) for HIV-HCV co-infected individuals living in Greece and investigated factors associated with different HCV-CoC stages. We analyzed data from 1213 participants from the Athens Multicenter AIDS Cohort Study. A seven-stage CoC, overall and by subgroup (people who inject drugs (PWID), men having sex with men (MSM), men having sex with women (MSW), and migrants], was constructed, spanning from HCV diagnosis to sustained virologic response (SVR). Logistic/Cox regression models were employed to identify factors associated with passing through each CoC step. Among 1213 anti-HCV-positive individuals, 9.2% died before direct-acting antiviral (DAA) availability. PWID exhibited higher mortality rates than MSM. Of 1101 survivors, 72.2% remained in care and underwent HCV-RNA testing. Migrants and PWID showed the lowest retention rates. HCV-RNA was available for 79.2% of those in care, with 77.8% diagnosed with chronic HCV. Subsequently, 71% initiated DAAs, with individuals with very low CD4 counts (<100 cells/μL) exhibiting lower odds of DAA initiation. SVR testing was available for 203 individuals, with 85.7% achieving SVR. The SVR rates did not differ across risk groups. In 2023, significant gaps and between-group differences persisted in HCV-CoC among HIV-HCV co-infected individuals in Greece.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Sexually Transmitted Infections
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

